https://www.selleckchem.com/pr....oducts/GSK1904529A.h
ble Exposure Limits (OSHA PELs) that are orders of magnitude above levels shown by published single toxic stimuli studies to have caused adverse effects. Practical considerations for the application of this approach are presented. The Spleen Tyrosine Kinase (SYK) is known for its involvement in B-cell and T-cell signaling, modulating the peripheral immune response. We have previously shown that SYK is overactive in the brains of human Alzheimer's Disease (AD) patients, as well as mouse models of AD and tauopathy including Tg Tau P30
Mi piace
Commento
Condividi
